The U.S, Court of Appeals for the Federal Circuit (CAFC) on Monday, January 6, rejected Laboratory Corporation of America Holdings’ (Labcorp) argument that, among other issues, the Patent Trial and Appeal Board (PTAB) erred in its motivation to combine analysis and ultimate determination that Labcorp had not proven Ravgen, Inc.’s patent claims to be obvious. The opinion was authored by Judge Lourie.
Recent Posts
- INTA Urges EUIPO Grand Board to Confirm Human Face Marks are Not Excluded from Trademark Registration
- New USPTO Fee Rule for Continuing Applications: Key Changes and Strategic Considerations for Applicants
- AI and the Level of Ordinary Skill: Why Patent Law Must (and Can) Adapt to AI-Augmented Invention
- Federal Circuit Upholds PTAB Win for Patent to Detect Genetic Disorders
- CAFC Says Patent Claims Need Not Explicitly Disclose Material Benefits for Trademark Functionality Doctrine